Prakt. lékáren. 2010; 6(2): 87-90

Immunosupressant dispensation and education of organ transplant recipients in chemist's

Mgr.Katarína Mikušová
Ústavní lékárna IKEM, Praha

Transplantation is considered as a „new chance for life“ for patients in end stage of a solid organ failure. However, it involves a lot of

restrictions in patient common life. Health care of organ transplant recipients entails regular medical examinations, regime and diet

recommendations and special rules in immunosupressive drug administration. These are necessary for solid organ graft acceptance

and its right function. There are more drugs used to lower risk of transplant complications or to treat other patient comorbidities in organ

transplant recipient medication. Patient with polypragmasy has to be explained rules how to take his medication to avoid potential

drug-drug or drug-food interactions. It is a role of pharmacist to provide right drug counselling and to give patient important diet and

regime recommendations.

Keywords: transplantation, immunosupressive drugs, drugcounselling, interactions

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mikušová K. Immunosupressant dispensation and education of organ transplant recipients in chemist's. Praktické lékárenství. 2010;6(2):87-90.
Download citation

References

  1. Viklický O, Janoušek L, Baláž P, et al. Transplantace ledviny v klinické praxi. Praha: Grada Publishing, 2008: 380 s.
  2. Adamec J, Saudek F. Transplantace slinivky břišní a diabetes mellitus. Praha: Karolinum, 2005: 163 s.
  3. Pirk J, Málek I, a kol. Transplantace srdce. Praha: Karolinum, 2008: 287 s.
  4. MV - AISLP, SPC.
  5. Katzung BG. Základní a klinická farmakologie. Jinočany: H&H Vyšehradská, 2006: 1106 s.
  6. Suchopár J, a kol. Kompendium lékových interakcí Infopharm(R) 2005. Infopharm, a.s., 2004.
  7. http://medicine.iupui.edu/flockhart/table.htm.
  8. Lynch T, Price A. Cytochrom P450, jeho vliv na metabolismus léčiv, jejich působení, interakce a nežádoucí účinky. Medicína po promoci, 2007; 8(6): 28-37.
  9. http://www.drugs.com/pro/azathioprine.html, přístup dne 25. ledna 2010.
  10. Magulová L, Božeková L, Kriška M. Interakcie liečiv v klinickej praxi. 2. doplnené a upravené vydanie. Slovak Academic Press, 2004: 333 s.
  11. Farmakologické interakce. Farmakoterapeutické informace, Měsíčník pro lékaře a farmaceuty 2000; 7-8: 1-8.
  12. El-Dahshan KF, Bakr MA, Donia AF, Badr, Ael-S, Sobh MA. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study, Am J Nephrol. 2006; 26(3): 293-8. Epub 2006 Jun 22. Go to original source... Go to PubMed...
  13. Keshari KJ, Kumar A, Kumar S, Sharma A, Rastogi P. Drug Interactions: Reactions with Grapefruit and Related Citrus Fruits. The Pharma Research, 2009; 1: 1-14.
  14. Slíva J, Patočková J. Lékové interakce grapefruitové šťávy a vybraných fytofarmak. Postgraduální medicína, publikováno dne: 5. 4. 2007.
  15. Egashira K, Ohtani H, Itoh S, Koyabu N, Tsujimoto M, Murakami H, Sawada Y. Inhibitory Effects of Pomelo on the Metabolism of Tacrolimus and the Activities of CYP3A4 and P-glycoprotein, Drug Metabolism and Disposition, 2004; 32(8): 828-833. Go to original source... Go to PubMed...
  16. Tůmová L, Bajerová J. Hypericum perforatum interakce s ostatními léky (I). Prakt. Lékáren. 2006; 1: 28-30.
  17. Pazderková J, Krejčí J, Dlouhý P. Listerióza přehled současných znalostí, Klinická mikrobiologie a infekční lékařství 2008, 4: 140-144.
  18. Qayyum QJ, Scerpella EG, Moreno JN, Fischl MA. Report of 24 cases of Listeria monocytogenes infection at the University of Miami Medical Center, Rev Invest Clin, 1997; 49(4): 265-270.
  19. Kruszyna T, Walsh M, Peltekian K, Molinari M. Early Invasive Listeria Monocytogenes Infection After Orthotopic Liver Transplantation: Case Report and Review of the Literature, Liver Transplantation 2008; 14: 88-91. Go to original source... Go to PubMed...
  20. Euvrad S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancers in transplant patients: Focus on rapamycin, Dermatolog. Surgery, 2004; 30: 628-633. Go to original source...
  21. Ho WL, Murphy GM. Update on the pathogenesis of posttransplant skin cancer in renal transplant recipients. British Journal of Dermatology 2008; 158: 217-224. Go to original source...
  22. Cetkovská P, Uhlíková H, Kumpová M, Reischig T. Kožní komplikace u pacientů po transplantaci ledvin. Orgánové transplantácie - multidisciplinárny časopis pre transplantačnú problematiku 2008; (4)1: 6.
  23. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols, Clinical Microbiology Reviews 2003; 357-364. Go to original source... Go to PubMed...
  24. Allen U, Blumberg EA, Fischer SA, Green M, Ison MG, Kotton CN, Kumar D, Michaels MG, Morris MI. American Society of Transplantation (AST) Infectious Disease Community of Practice/Transplant Infectious Disease Section of The Transplantation Society (TTS) Guidance On Novel Influenza A/H1N1, AST ID COP/TID section of TTS Novel Influenza A/ H1N1 Working Group Members 2009.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.